ArfGAP with Dual Pleckstrin Homology Domains 2 Promotes Hypertrophy of Cultured Neonatal Cardiomyocytes
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157588 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jonathan Berthiaume und 5 weiteren Autor:innen. Beteiligte Einrichtung: Département de Médecine-Service de Cardiologie, Centre de Recherche du CHUS, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrook…. Hauptthemen laut MEDLINE: Myocytes, Cardiac, GTPase-Activating Proteins, Cardiomegaly. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council, Canadian Institute of Health Research (CIHR) Frederick Banting & Charles Best Canada graduate scholarships-doctoral award, FRQS fellowship.
Abstract (Originalsprache)
Cardiomyocyte hypertrophy is regulated by several factors, including the ADP-ribosylation factor (Arf) family of small G proteins, among others. For instance, ArfGAP with dual pleckstrin homology domains 1 (Adap1) exerts an anti-hypertrophic effect in cultured cardiomyocytes. Its homologous protein, Adap2, is also expressed in the heart but its role remains elusive. To elucidate its function, we investigated the effects of adenoviral-mediated overexpression of Adap2 in cultured neonatal rat ventricular myocytes under both basal and pro-hypertrophic conditions, employing a range of microscopy and biochemical techniques. Despite minimal detection in neonatal rat hearts, Adap2 was found to be well expressed in adult rat hearts, being predominantly localized at the membrane fraction. In contrast to Adap1, overexpression of Adap2 provokes the robust accumulation of β1-integrin at the cellular surface of cultured cardiomyocytes. Interestingly, overexpressed Adap2 relocalizes at the sarcolemma and increases the size of cardiomyocytes upon phenylephrine stimulation, despite attenuating Erk1/2 phosphorylation and Nppa gene expression. Under these same conditions, cardiomyocytes overexpressing Adap2 also express higher level of detyrosinated tubulin, a marker of hypertrophic response. These findings provide new insights into the pro-hypertrophic function of Adap2 in cardiomyocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Département de Médecine-Service de Cardiologie, Centre de Recherche du CHUS, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
- Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
ORCID-Profile: Lauralyne Dumont, Hugo Giguère, Mannix Auger-Messier
Förderung
- Natural Sciences and Engineering Research Council
- Canadian Institute of Health Research (CIHR) Frederick Banting & Charles Best Canada graduate scholarships-doctoral award
- FRQS fellowship
- CIHR fellowship
- Natural Sciences and Engineering Research Council of Canada (NSERC) Alexander-Graham-Bell graduate scholarship-doctoral award
- NSERC discovery grant
- FRQS–Senior research scholarship-career award
Zitieren
APA
Berthiaume, J., Dumont, A. A., Dumont, L., Roy, M. F., Giguère, H., & Auger-Messier, M. (2025). ArfGAP with Dual Pleckstrin Homology Domains 2 Promotes Hypertrophy of Cultured Neonatal Cardiomyocytes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157588
Vancouver
Berthiaume J, Dumont AA, Dumont L, Roy MF, Giguère H, Auger-Messier M. ArfGAP with Dual Pleckstrin Homology Domains 2 Promotes Hypertrophy of Cultured Neonatal Cardiomyocytes. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157588
BibTeX
@article{Berthiaume2025,
author = {Berthiaume, Jonathan and Dumont, Audrey-Ann and Dumont, Lauralyne and Roy, Marie-Frédérique and Giguère, Hugo and Auger-Messier, Mannix},
title = {ArfGAP with Dual Pleckstrin Homology Domains 2 Promotes Hypertrophy of Cultured Neonatal Cardiomyocytes},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157588}
}
EUVIMED